C D Schteingart
Impact in
- Oncology top 5%
- Drug Transport and Resistance Mechanisms
- Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism
Papers in
- Co-authors
- Alan F. Hofmann (12 shared papers)H.-T. Ton-Nu (13 shared papers)Lee R. Hagey (10 shared papers)A.F. Hofmann (6 shared papers)Alan F. Hofmann (7 shared papers)Jan Lillienau (1 shared paper)Kim E. Barrett (1 shared paper)Cornelia M. Gelbmann (1 shared paper)
- Journals
- Journal of Lipid Research (12 papers)American Journal of Physiology-Gastrointestinal and Liver Physiology (3 papers)Hepatology (3 papers)Journal of Biological Chemistry (2 papers)Journal of Clinical Investigation (2 papers)
- Partner nations
- United StatesFranceJapan
In The Last Decade
C D Schteingart
31 papers receiving 797 citations
Peers
Comparison fields: 5 of 84
- Oncology 534
- Pharmacology 91
- Gastroenterology 56
- Clinical Biochemistry 59
- Hepatology 69
Countries citing papers authored by C D Schteingart
This map shows the geographic impact of C D Schteingart's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C D Schteingart with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C D Schteingart more than expected).
Fields of papers citing papers by C D Schteingart
This network shows the impact of papers produced by C D Schteingart. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C D Schteingart. The network helps show where C D Schteingart may publish in the future.
Co-authors
The 25 scholars most cited alongside C D Schteingart, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1993 | 81 | |
| 2 | 1995 | 62 | |
| 3 | 1992 | 62 | |
| 4 | 1988 | 61 | |
| 5 | 1992 | 49 | |
| 6 | 1994 | 48 | |
| 7 | 1992 | 45 | |
| 8 | 1997 | 44 | |
| 9 | 1990 | 41 | |
| 10 | 1997 | 33 | |
| 11 | 1997 | 28 | |
| 12 | 1988 | 27 | |
| 13 | 1989 | 22 | |
| 14 | 1994 | 20 | |
| 15 | 1996 | 20 | |
| 16 | 2002 | 20 | |
| 17 | 1991 | 19 | |
| 18 | 1994 | 19 | |
| 19 | 1997 | 17 | |
| 20 | 1996 | 15 |
About C D Schteingart
C D Schteingart is a scholar working on Oncology, Surgery, Molecular Biology, Gastroenterology and Clinical Biochemistry, having authored 31 papers that have together received 824 indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (23 papers), Pediatric Hepatobiliary Diseases and Treatments (9 papers), Metabolism and Genetic Disorders (4 papers), Animal Nutrition and Physiology (3 papers), Pharmacogenetics and Drug Metabolism (3 papers), Cannabis and Cannabinoid Research (3 papers), Gastroesophageal reflux and treatments (3 papers) and Gallbladder and Bile Duct Disorders (3 papers). The work is most often cited by research in Oncology (534 citations), Pharmacology (91 citations), Gastroenterology (56 citations), Clinical Biochemistry (59 citations) and Hepatology (69 citations). C D Schteingart has collaborated with scholars based in United States, France and Japan. Frequent co-authors include Alan F. Hofmann, H.-T. Ton-Nu, Lee R. Hagey, A.F. Hofmann, Alan F. Hofmann, Jan Lillienau, Kim E. Barrett, Cornelia M. Gelbmann, Steven S. Rossi and Phillip B. Hylemon. Their work appears in journals such as Journal of Lipid Research, American Journal of Physiology-Gastrointestinal and Liver Physiology, Hepatology, Journal of Biological Chemistry and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.